Oncologist 🇱🇰 Editor-in-Chief RCR Open @RCRadiologists

Sri Lanka
Joined December 2008
The protocol for our HYPOCON #trial for locally advanced #HNSCC is out in @ClinicalOnc Investigating an innovative biphasic #radiotherapy #fractionation schedule across #SriLanka. Brilliant collaboration with @remediumone @sueyom @achoud72 #RadOnc authors.elsevier.com/a/1nqW6…
1
4
376
Replying to @MCRCnews
Treatment of the primary after exceptional response in metastatic #BladderCancer. @achoud72 @TheChristieNHS and Alexandra Masson-Lecomte, MD, MS @HopSaintLouis join @shilpaonc @ClevelandClinic to discuss on UroToday. #WatchNow > bit.ly/4hY7FvW @IBCG_BladderCA #IBCG2026 #IBCG26 @UroDocAsh
2
4
221
Nuradh Joseph retweeted
For Christians, the poor are not a sociological category, but the very ‘flesh’ of Christ. Christ, poor and crucified, continues to allow Himself to be encountered and loved through these men and women, who call us to go beyond ourselves and to dare to practice charity. #ApostolicJourney #France vatican.va/content/leo-xiv/e…
241
1,295
74
8,947
443,219
It is the same globally and more so in #LMIC s. Pragmatic #clinicalresearch is not only under-funded #HealthPolicy makers but also under-valued by #clinicians themselves. #GlobalOncology #Oncology #Radonc @achoud72 @NicholasZaorsky
In American medicine, research is the price of admission but rarely a viable career. Trainees are told it's essential for competitive medical school and residency positions. As faculty, they confront scarce protected time, billing-driven productivity metrics, low grant-funding rates, long funding cycles, and salary-cap gaps their institutions are asked to absorb, just as family and financial obligations grow. Pragmatic clinical research is poorly supported, especially outside well-resourced centers. The incentives favor delivering costly care over improving it.
1
213
Nuradh Joseph retweeted
Although highly effective, many novel cancer therapeutics for early NSCLC prove to be prohibitively expensive. This comprehensive cost–utility analysis using an LMIC-appropriate willingness-to-pay threshold sought to identify economically viable options bmjoncology.bmj.com/content/…,
1
3
184
Nuradh Joseph retweeted
"Our analyses show that in Sri Lanka’s state health system, four approved indications of novel cancer therapeutics for stage II-III NSCLC emerged as cost-effective at the primary willingness-to-pay threshold of US$6700 per QALY" 🔗 bmjoncology.bmj.com/content/…
1
2
214
Nuradh Joseph retweeted
This was a particularly great year for #ASCOBT26 with impressive representation from South Asia! This meeting is becoming a go-to in Asia and I'm happy to see its rapid development! @ASCO
Privileged to speak at #ASCOBreakthrough2026 on the intersection of #MolecularRadiotherapy and #Immunotherapy #ASCOBT26. Finally got to catchup with @achoud72 and meet @sueyom! @ASCO #radonc #oncology
2
4
13
2,539
Privileged to speak at #ASCOBreakthrough2026 on the intersection of #MolecularRadiotherapy and #Immunotherapy #ASCOBT26. Finally got to catchup with @achoud72 and meet @sueyom! @ASCO #radonc #oncology
1
3
2
14
3,862
👏🏻Congratulations to Prof. Chandima Jeewandara on being appointed the first Director of the Institute of Allergology and Immunology. 🔬A landmark moment for our newly established institute at @usjp, advancing immunology, allergology, molecular medicine & biomedical engineering.
2
3
1
7
613
An early morning for #whereishoskin as he kicks off the @slconcology annual meeting with a breakfast session on #cancerresearch Lots of practical tips and wisdom from the legend himself.. Hope this translates into more #cancerresearch in #SriLanka @MCRCnews @hiprabs #oncology
2
8
460
Healthcare & hashtags - a delicate balance An insightful keynote at the @slconcology annual meeting by the brilliant @sanjanah on #medical #disinformation on #socialmedia which spreads like cancer & metastatises in society leaving an incurable legacy of harm #srilanka @Gunti777
1
2
4
624
Nuradh Joseph retweeted
GLP-1 Receptor Agonists are powerful new💉 in assising weight loss, but do they cause cancer? Just out in @JAMAOnc study in people from Florida with obesity ➡️Bottom line cancer incidence is lower overall in those taking GLP-1RA (HR=0.83 0.76-0.91) 🔗jamanetwork.com/journals/jam…
3
8
751
THE conference where everyone brought their A-game! 1st ever APCCC South Asia 🇮🇳🇱🇰🇳🇵🇧🇩 edition😇 Fortunate to be a part of wonderfully exhaustive discussion s on everything in prostate cancer!
Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx. Plenty of friendly banter and leg pulling. Official APCCC South Asia. Paper with similarities yet differences from @APCCC_Lugano coming soon.
3
28
1,156
Thanks so much @VedangMurthy for putting together the first ever #APCCC #SouthAsia and for including #SriLanka. It was great to meet so many colleagues from #SouthAsia #Prostatecancer #oncology @Vimukthini @YasiruMalinda @docpriyamvada
Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx. Plenty of friendly banter and leg pulling. Official APCCC South Asia. Paper with similarities yet differences from @APCCC_Lugano coming soon.
3
7
825
Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx. Plenty of friendly banter and leg pulling. Official APCCC South Asia. Paper with similarities yet differences from @APCCC_Lugano coming soon.
4
16
4
81
7,133
#Repurposing Medications for #PalliativeCare - An insightful review authored by Sudhakaran, Das and Kondasinghe published in #RCROpen @RCRadiologists Useful practical tips for all #clinicians! #oncology #cancer @ClinOncology @OncologyAdvance sciencedirect.com/science/ar…
1
1
69